222 related articles for article (PubMed ID: 22750941)
21. Parathyroidectomy: still the best choice for the management of severe secondary hyperparathyroidism.
Ramos LGF; Cortes DDPVR; Reis LMD; Montenegro FLM; Arap SS; Brescia MDG; Custódio MR; Jorgetti V; Elias RM; Moysés RMA
J Bras Nefrol; 2024; 46(2):e20230024. PubMed ID: 38039492
[TBL] [Abstract][Full Text] [Related]
22. Treatment of Secondary Hyperparathyroidism and Posttransplant Tertiary Hyperparathyroidism.
Egan CE; Qazi M; Lee J; Lee-Saxton YJ; Greenberg JA; Beninato T; Zarnegar R; Fahey TJ; Finnerty BM
J Surg Res; 2023 Nov; 291():330-335. PubMed ID: 37506432
[TBL] [Abstract][Full Text] [Related]
23. Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism.
Komaba H; Taniguchi M; Wada A; Iseki K; Tsubakihara Y; Fukagawa M
Kidney Int; 2015 Aug; 88(2):350-9. PubMed ID: 25786097
[TBL] [Abstract][Full Text] [Related]
24. The Effect of Cinacalcet on Calcific Uremic Arteriolopathy Events in Patients Receiving Hemodialysis: The EVOLVE Trial.
Floege J; Kubo Y; Floege A; Chertow GM; Parfrey PS
Clin J Am Soc Nephrol; 2015 May; 10(5):800-7. PubMed ID: 25887067
[TBL] [Abstract][Full Text] [Related]
25. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Role of cinacalcet in the treatment of CKD-MBD].
Koiwa F; Maruta Y
Clin Calcium; 2010 Jul; 20(7):1089-95. PubMed ID: 20585188
[TBL] [Abstract][Full Text] [Related]
26. A Randomized Study Comparing Parathyroidectomy with Cinacalcet for Treating Hypercalcemia in Kidney Allograft Recipients with Hyperparathyroidism.
Cruzado JM; Moreno P; Torregrosa JV; Taco O; Mast R; Gómez-Vaquero C; Polo C; Revuelta I; Francos J; Torras J; García-Barrasa A; Bestard O; Grinyó JM
J Am Soc Nephrol; 2016 Aug; 27(8):2487-94. PubMed ID: 26647424
[TBL] [Abstract][Full Text] [Related]
27. Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism.
Block GA; Zeig S; Sugihara J; Chertow GM; Chi EM; Turner SA; Bushinsky DA;
Nephrol Dial Transplant; 2008 Jul; 23(7):2311-8. PubMed ID: 18310602
[TBL] [Abstract][Full Text] [Related]
28. Cinacalcet versus Parathyroidectomy in the Treatment of Secondary Hyperparathyroidism Post Renal Transplantation.
Soliman AR; Maamoun HA; Soliman MA; Darwish H; Elbanna E
Rom J Intern Med; 2016 Sep; 54(3):184-189. PubMed ID: 27658167
[TBL] [Abstract][Full Text] [Related]
29. Histology and immunohistochemistry of the parathyroid glands in renal secondary hyperparathyroidism refractory to vitamin D or cinacalcet therapy.
Vulpio C; Bossola M; Di Stasio E; Tazza L; Silvestri P; Fadda G
Eur J Endocrinol; 2013 Jun; 168(6):811-9. PubMed ID: 23520248
[TBL] [Abstract][Full Text] [Related]
30. [Long-term efficacy of parathyroidectomy in secondary and tertiary hyperparathyroidism].
González-Cantú A; Romero-Ibarguengoitia ME; Quintanilla-Flores DL; Reza-Albarrán A; Herrera-Hernández M; Pantoja-Millán JP; Sierra-Salazar M; Velázquez-Fernández D; Gómez-Pérez FJ
Rev Med Inst Mex Seguro Soc; 2019 Dec; 57(6):371-378. PubMed ID: 33001613
[TBL] [Abstract][Full Text] [Related]
31. Short-term use of cinacalcet in children on regular hemodialysis.
Youssef D
Arab J Nephrol Transplant; 2012 Jan; 5(1):51-3. PubMed ID: 22283867
[TBL] [Abstract][Full Text] [Related]
32. [Bone and calcium update; diagnosis and therapy of metabolic bone disease update. Advances in treatment of CKD-MBD].
Mizobuchi M; Nakazawa A; Akizawa T
Clin Calcium; 2011 Dec; 21(12):159-66. PubMed ID: 22133835
[TBL] [Abstract][Full Text] [Related]
33. Calcimimetics in the chronic kidney disease-mineral and bone disorder.
Bover J; Aguilar A; Baas J; Reyes J; Lloret MJ; Farré N; Olaya M; Canal C; Marco H; Andrés E; Trinidad P; Ballarin J
Int J Artif Organs; 2009 Feb; 32(2):108-21. PubMed ID: 19363783
[TBL] [Abstract][Full Text] [Related]
34. Surgical indications and procedures of parathyroidectomy in patients with chronic kidney disease.
Tominaga Y; Matsuoka S; Sato T
Ther Apher Dial; 2005 Feb; 9(1):44-7. PubMed ID: 15828905
[TBL] [Abstract][Full Text] [Related]
35. Management of secondary hyperparathyroidism in the elderly patient with chronic kidney disease.
Cozzolino M; Gallieni M; Pasho S; Fallabrino G; Ciceri P; Volpi EM; Olivi L; Brancaccio D
Drugs Aging; 2009; 26(6):457-68. PubMed ID: 19591520
[TBL] [Abstract][Full Text] [Related]
36. Impact of Parathyroidectomy Versus Oral Cinacalcet on Bone Mineral Density in Patients on Peritoneal Dialysis With Advanced Secondary Hyperparathyroidism: The PROCEED Pilot Randomized Trial.
Wang AY; Tang TK; Yau YY; Lo WK
Am J Kidney Dis; 2024 Apr; 83(4):456-466.e1. PubMed ID: 38040277
[TBL] [Abstract][Full Text] [Related]
37. Survival after parathyroidectomy in chronic hemodialysis patients with severe secondary hyperparathyroidism.
Moldovan D; Racasan S; Kacso IM; Rusu C; Potra A; Bondor C; Patiu IM; Gherman-Căprioară M
Int Urol Nephrol; 2015 Nov; 47(11):1871-7. PubMed ID: 26377492
[TBL] [Abstract][Full Text] [Related]
38. Treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
Komaba H; Tanaka M; Fukagawa M
Intern Med; 2008; 47(11):989-94. PubMed ID: 18520108
[TBL] [Abstract][Full Text] [Related]
39. The effect of cinacalcet on intraoperative findings in tertiary hyperparathyroidism patients undergoing parathyroidectomy.
Somnay YR; Weinlander E; Schneider DF; Sippel RS; Chen H
Surgery; 2014 Dec; 156(6):1308-13; discussion 1313-4. PubMed ID: 25456900
[TBL] [Abstract][Full Text] [Related]
40. Parathyroidectomy vs Cinacalcet Among Patients Undergoing Hemodialysis.
Komaba H; Hamano T; Fujii N; Moriwaki K; Wada A; Masakane I; Nitta K; Fukagawa M
J Clin Endocrinol Metab; 2022 Jun; 107(7):2016-2025. PubMed ID: 35277957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
